Professor Philip Quirke

Phil is Head of Pathology and Data Analytics at the University of Leeds, UK and a gastrointestinal pathologist by training with a long standing interest in bowel cancer (BC). He contributed to improving BC surgery and its pathological assessment in the UK and around the world. He has been on the trial management groups of major national and international phase 3 trials on surgery (Clasicc, Rolar), chemotherapy (Quasar, Focus 1-4,Foxtrot) and radiotherapy (CR07, Aristotle) as well as many phase 2 trials. He also chairs the NHS pathology committee since 2006, contributing to EU guidance.

His current research interests are identifying the early steps in the formation of BCs, the role of the microbiome in causation, screening and treatment of BC, the use of molecular pathology in the treatment of BC and improving treatment pathway’s and clinical outcomes through the use of big data and feed back to multidisciplinary teams to improve performance.